Cassava Sciences SAVA Stock
22.75 USD
{{ price }}
-12.868635%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
United States
Exchange
NasdaqCM
Market Cap
983.84M USD
LOW - HIGH [24H]
22.5
-
26.44 USD
VOLUME [24H]
1.88M USD
{{ volume }}
P/E Ratio
0
Earnings per share
-2.32 USD
Cassava Sciences Price Chart
Cassava Sciences SAVA Financial and Trading Overview
| Cassava Sciences stock price | 22.75 USD |
| Previous Close | 25.33 USD |
| Open | 25.16 USD |
| Bid | 0 USD x 900 |
| Ask | 0 USD x 1000 |
| Day's Range | 24.92 - 25.33 USD |
| 52 Week Range | 13.84 - 51.59 USD |
| Volume | 343.23K USD |
| Avg. Volume | 674.12K USD |
| Market Cap | 1.05B USD |
| Beta (5Y Monthly) | -0.137676 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.32 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | December 13, 2012 |
| 1y Target Est | 112 USD |
SAVA Valuation Measures
| Enterprise Value | 870.05M USD |
| Trailing P/E | N/A |
| Forward P/E | -13.927778 |
| PEG Ratio (5 yr expected) | -0.39 |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 5.130986 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -9.963 |
Trading Information
Cassava Sciences Stock Price History
| Beta (5Y Monthly) | -0.137676 |
| 52-Week Change | -6.87% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 51.59 USD |
| 52 Week Low | 13.84 USD |
| 50-Day Moving Average | 24.01 USD |
| 200-Day Moving Average | 30.16 USD |
SAVA Share Statistics
| Avg. Volume (3 month) | 674.12K USD |
| Avg. Daily Volume (10-Days) | 612.78K USD |
| Shares Outstanding | 41.75M |
| Float | 39.28M |
| Short Ratio | 12.83 |
| % Held by Insiders | 6.00% |
| % Held by Institutions | 27.18% |
| Shares Short | 10.8M |
| Short % of Float | 27.46% |
| Short % of Shares Outstanding | 25.87% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:7 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -23.98% |
| Return on Equity (ttm) | -37.62% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -68032000 USD |
| EBITDA | -87332000 USD |
| Net Income Avi to Common (ttm) | -82990000 USD |
| Diluted EPS (ttm) | -2.02 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 187.47M USD |
| Total Cash Per Share (mrq) | 4.49 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 14.02 |
| Book Value Per Share (mrq) | 4.886 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -67239000 USD |
| Levered Free Cash Flow (ttm) | -42271376 USD |
Profile of Cassava Sciences
| Country | United States |
| State | TX |
| City | Austin |
| Address | 6801 N. Capital of Texas Hwy, Bldg 1 |
| ZIP | 78731 |
| Phone | 512 501 2444 |
| Website | https://www.cassavasciences.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 26 |
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. The company was incorporated in 1998 and is based in Austin, Texas.
Q&A For Cassava Sciences Stock
What is a current SAVA stock price?
Cassava Sciences SAVA stock price today per share is 22.75 USD.
How to purchase Cassava Sciences stock?
You can buy SAVA shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Cassava Sciences?
The stock symbol or ticker of Cassava Sciences is SAVA.
Which industry does the Cassava Sciences company belong to?
The Cassava Sciences industry is Biotechnology.
How many shares does Cassava Sciences have in circulation?
The max supply of Cassava Sciences shares is 43.25M.
What is Cassava Sciences Price to Earnings Ratio (PE Ratio)?
Cassava Sciences PE Ratio is now.
What was Cassava Sciences earnings per share over the trailing 12 months (TTM)?
Cassava Sciences EPS is -2.32 USD over the trailing 12 months.
Which sector does the Cassava Sciences company belong to?
The Cassava Sciences sector is Healthcare.
Cassava Sciences SAVA included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| Nasdaq US 700 Small Cap Index NQUS700SC | 2060.1 USD — |
-1.99
|
— — | 2051.95 USD — | 2093.4 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
| NASDAQ Capital Market Composite RCMP | 114.55 USD — |
-2.27
|
— — | 114.09 USD — | 116.72 USD — | — - | — — |
- {{ link.label }} {{link}}